These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2766368)

  • 21. Discordant results in human chorionic gonadotropin assays.
    Cole LA; Kardana A
    Clin Chem; 1992 Feb; 38(2):263-70. PubMed ID: 1371722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
    Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
    Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical evaluation of the simultaneous measurements of human chorionic gonadotropin (hCG) and its alpha-subunit in sera of patients with trophoblastic diseases.
    Nishimura R; Ashitaka Y; Tojo S
    Endocrinol Jpn; 1979 Oct; 26(5):575-83. PubMed ID: 527560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
    Yuen BH; Cannon W; Benedet JL; Boyes DA
    Am J Obstet Gynecol; 1977 Apr; 127(7):711-2. PubMed ID: 557901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of radioimmunoassay of serum human chorionic gonadotropin in the management of choriocarcinoma.
    Gupta SK; Buckshee K; Talwar GP
    J Assoc Physicians India; 1985 Feb; 33(2):144-7. PubMed ID: 2581931
    [No Abstract]   [Full Text] [Related]  

  • 26. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
    Cole LA; Shahabi S; Butler SA; Mitchell H; Newlands ES; Behrman HR; Verrill HL
    Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Choriocarcinoma associated with undetectable levels of human chorionic gonadotropin.
    Lemonnier MC; Glezerman M; Vauclair R; Audet-Lapointe P
    Gynecol Oncol; 1986 Sep; 25(1):48-52. PubMed ID: 3732917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of radioimmunoassays using mono- and polyclonal antibodies for the quantitation of human chorionic gonadotropin in early pregnancy.
    Heip J; Liu Y; Devroey P; Naaktgeboren N; Van Steirteghem AC
    Ann Biol Clin (Paris); 1986; 44(2):131-8. PubMed ID: 3752628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the beta-Neocept test for early pregnancy.
    Yuen BH; Pride SM; Callegari PB
    Can Med Assoc J; 1984 Sep; 131(6):583-5. PubMed ID: 6206935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Modulation of hCG synthesis by alpha tumor necrosis factor in JAR choriocarcinoma cells].
    Marth C; Madersbacher S; Herold M; Berger P; Hetzel H; Fuith LC; Daxenbichler G
    Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):122-3. PubMed ID: 2318404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibodies against beta-human chorionic gonadotropin. A comparative immunohistochemical study.
    Schaldenbrand J; Lloyd RV; Khazaeli MB
    Arch Pathol Lab Med; 1984 Sep; 108(9):704-6. PubMed ID: 6205635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB; Lehr M; Lewis JL
    Surg Forum; 1973; 24():563-5. PubMed ID: 4377042
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization of human chorionic gonadotropin in urine of patients with trophoblastic diseases by Western blotting using specific antibodies.
    Nishimura R; Utsunomiya T; Ide K; Kitajima T; Chen HC; Strobel JL; Hussa RO; Mochizuki M
    Jpn J Cancer Res; 1987 Aug; 78(8):833-9. PubMed ID: 3115930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioimmunolocalization of monoclonal antibodies to human chorionic gonadotropin in choriocarcinoma transplanted into athymic mice.
    Hattori S; Mano H; Furuhashi Y; Goto S; Tomoda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):743-50. PubMed ID: 2582070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M; Darwish NA; Abdel-Aziz O
    J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies with choriocarcinoma and normal pregnancy serum chorionic gonadotrophin.
    Mwenda JM; Bambra CS; Onchiri F
    East Afr Med J; 1989 Jan; 66(1):2-9. PubMed ID: 2917494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management and outcome of healthy women with a persistently elevated beta-hCG.
    Palmieri C; Dhillon T; Fisher RA; Young AM; Short D; Mitchell H; Aghajanian C; Savage PM; Newlands ES; Hancock BW; Seckl MJ
    Gynecol Oncol; 2007 Jul; 106(1):35-43. PubMed ID: 17482245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of rapid radioimmunoassay for urinary beta-human chorionic gonadotropin (beta hCG-RIA) in early pregnancy.
    Xu RQ; Li YY; Zhou SZ; Fei RT; Liu YH
    Acta Acad Med Wuhan; 1984; 4(2):105-8. PubMed ID: 6204259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum relaxin in patients with invasive mole, choriocarcinoma and persistent trophoblastic disease.
    Seki K; Uesato T; Kato K
    Endocrinol Jpn; 1986 Oct; 33(5):727-33. PubMed ID: 3030714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI; Kacinski BM; Stanley ER
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.